2023
DOI: 10.1016/j.htct.2021.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 10 publications
(24 reference statements)
0
0
0
Order By: Relevance